Article
Pharma In Brief - Federal Court Grants Injunction That Allows Infringing Biologic Drug To Stay On The Market
The Federal Court has granted a limited permanent injunction to AbbVie against Janssen Inc. ("Janssen") preventing certain marketing activities in respect of the sale of STELARA® in Canada.
Norton Rose Fulbright Canada LLP
